07/01/2025
11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
07/01/2025
11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
07/01/2025
11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
07/01/2025
11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
07/01/2025
11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
07/01/2025
11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
07/01/2025
11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
07/01/2025
11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
06/27/2025
4:05 PM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2025
4:06 PM | Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2025
4:06 PM | Klassen Preston (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RGLS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Regulus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/27/2025
4:09 PM | Regulus Therapeutics (Issuer)
Rosen Hugh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2025
4:11 PM | PAPADOPOULOS STELIOS (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2025
4:12 PM | Regulus Therapeutics (Issuer)
Witz Pascale (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2025
4:12 PM | RASTETTER WILLIAM H (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2025
8:32 AM | Regulus Therapeutics (Filer)
| Form POS AM | |
06/25/2025
8:33 AM | Regulus Therapeutics (Filer)
| Form POS AM | |
06/25/2025
8:34 AM | Regulus Therapeutics (Filer)
| Form POS AM | |
06/25/2025
8:30 AM | Regulus Therapeutics (Filer)
| Form POS AM | |
06/25/2025
8:30 AM | Regulus Therapeutics (Filer)
| Form POS AM | |
06/25/2025
8:30 AM | Regulus Therapeutics (Filer)
| Form POS AM | |
06/25/2025
8:31 AM | Regulus Therapeutics (Filer)
| Form POS AM | |
06/25/2025
8:31 AM | Regulus Therapeutics (Filer)
| Form POS AM | |
06/25/2025
8:12 AM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2025
8:14 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:16 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:16 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:17 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:18 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:18 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:18 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:19 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:19 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:19 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:20 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:20 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:21 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:21 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:24 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:24 AM | NOVARTIS AG (Filed by)
Regulus Therapeutics (Subject)
| Form SC TO-T/A | |
06/25/2025
8:24 AM | Regulus Therapeutics (Subject)
| Form SC 14D9/A | |
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer? (Ad) Something extraordinary is happening in Washington.
For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations.
I'm talking about a $150 trillion American asset that's scattered across all 50 states.
While the mainstream media focuses on political theater, this story is quietly developing behind closed doors. We recently interviewed Rickards to get the full story and understand how everyday Americans can pre |
06/25/2025
8:24 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:25 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:25 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:26 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
8:28 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025
7:37 AM | Nasdaq Stock Market LLC (Filed by)
Regulus Therapeutics (Subject)
| Form 25-NSE | |
06/23/2025
6:00 AM | Regulus Therapeutics (Subject)
| Form SC 14D9/A | |
06/23/2025
5:02 AM | NOVARTIS AG (Filed by)
Regulus Therapeutics (Subject)
| Form SC TO-T/A | |
06/17/2025
5:30 AM | NOVARTIS AG (Filed by)
Regulus Therapeutics (Subject)
| Form SC TO-T/A | |
06/17/2025
5:32 AM | Regulus Therapeutics (Subject)
| Form SC 14D9/A | |
05/27/2025
7:48 AM | Regulus Therapeutics (Subject)
| Form SC 14D9 | |
05/27/2025
5:56 AM | NOVARTIS AG (Filed by)
Regulus Therapeutics (Subject)
| Form SC TO-T | |
05/15/2025
7:35 AM | Regulus Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/08/2025
7:23 PM | Regulus Therapeutics (Subject)
| Form SC14D9C | |
05/01/2025
4:00 PM | NOVARTIS AG (Filed by)
Regulus Therapeutics (Subject)
| Form SC TO-C | |
04/30/2025
5:16 PM | Nunn Jason Raleigh (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
4:00 PM | NOVARTIS AG (Filed by)
Regulus Therapeutics (Subject)
| Form SC TO-C | |
04/30/2025
7:27 AM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
7:30 AM | Regulus Therapeutics (Subject)
| Form SC14D9C | |
03/27/2025
6:15 AM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2025
4:00 PM | CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
4:00 PM | Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
4:00 PM | BALTIMORE DAVID (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
4:00 PM | Klassen Preston (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
4:00 PM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
3:14 PM | Regulus Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/15/2025
4:00 PM | Klassen Preston (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
4:00 PM | CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
4:00 PM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
4:00 PM | Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
3:32 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
1:35 PM | DAFNA Capital Management LLC (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024
3:26 PM | Regulus Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024
3:02 PM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G | |
08/08/2024
3:24 PM | Regulus Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024
3:18 PM | Collier Kathryn J (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
